Does new bill hold future of FDA?

摘要

If you look at this stuff, about all you can say is, 'Oh, man.' Oh, man, does Congressman John Dingell seem mad at FDA. For one thing, the Congressman could be found in late April butting heads with FDA commissioner Andrew Von Eschenbach at a hearing, berating the commissioner over the heparin tragedy that appears linked to foreign manufacturers that FDA is supposed to inspect.rnThe New York Times described Dingell as complaining that, to quote the Times, "he's tired of hearing from FDA commissioners about conducting business in new, innovative ways in place of additional financial resources," and that, "commissioners have talked about the need for the agency to be leaner and meaner. But it's turned out that it's leaner, weaker, and less capable of doing its job."